68 related articles for article (PubMed ID: 21968200)
1. Use of Cre/loxP recombination to swap cell binding motifs on the adenoviral capsid protein IX.
Poulin KL; Tong G; Vorobyova O; Pool M; Kothary R; Parks RJ
Virology; 2011 Nov; 420(2):146-55. PubMed ID: 21968200
[TBL] [Abstract][Full Text] [Related]
2. Bovine adenovirus type 3 containing heterologous protein in the C-terminus of minor capsid protein IX.
Zakhartchouk A; Connors W; van Kessel A; Tikoo SK
Virology; 2004 Mar; 320(2):291-300. PubMed ID: 15016551
[TBL] [Abstract][Full Text] [Related]
3. Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion.
Li J; Le L; Sibley DA; Mathis JM; Curiel DT
Virology; 2005 Aug; 338(2):247-58. PubMed ID: 15996701
[TBL] [Abstract][Full Text] [Related]
4. Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX.
Vellinga J; Rabelink MJ; Cramer SJ; van den Wollenberg DJ; Van der Meulen H; Leppard KN; Fallaux FJ; Hoeben RC
J Virol; 2004 Apr; 78(7):3470-9. PubMed ID: 15016870
[TBL] [Abstract][Full Text] [Related]
5. Abolition of hCAR-dependent cell tropism using fiber knobs of Atadenovirus serotypes.
Renaut L; Colin M; Leite JP; Benko M; D'Halluin JC
Virology; 2004 Apr; 321(2):189-204. PubMed ID: 15051380
[TBL] [Abstract][Full Text] [Related]
6. Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting.
Campos SK; Barry MA
Virology; 2006 Jun; 349(2):453-62. PubMed ID: 16504233
[TBL] [Abstract][Full Text] [Related]
7. Protein transduction domains fused to virus receptors improve cellular virus uptake and enhance oncolysis by tumor-specific replicating vectors.
Kühnel F; Schulte B; Wirth T; Woller N; Schäfers S; Zender L; Manns M; Kubicka S
J Virol; 2004 Dec; 78(24):13743-54. PubMed ID: 15564483
[TBL] [Abstract][Full Text] [Related]
8. Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.
Dmitriev IP; Kashentseva EA; Curiel DT
J Virol; 2002 Jul; 76(14):6893-9. PubMed ID: 12072490
[TBL] [Abstract][Full Text] [Related]
9. Fiber-mosaic adenovirus as a novel approach to design genetically modified adenoviral vectors.
Pereboeva L; Komarova S; Mahasreshti PJ; Curiel DT
Virus Res; 2004 Sep; 105(1):35-46. PubMed ID: 15325079
[TBL] [Abstract][Full Text] [Related]
10. Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors.
Sargent KL; Ng P; Evelegh C; Graham FL; Parks RJ
Gene Ther; 2004 Mar; 11(6):504-11. PubMed ID: 14999222
[TBL] [Abstract][Full Text] [Related]
11. Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX.
Poulin KL; Lanthier RM; Smith AC; Christou C; Risco Quiroz M; Powell KL; O'Meara RW; Kothary R; Lorimer IA; Parks RJ
J Virol; 2010 Oct; 84(19):10074-86. PubMed ID: 20631131
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus protein IX: a new look at an old protein.
Parks RJ
Mol Ther; 2005 Jan; 11(1):19-25. PubMed ID: 15585402
[TBL] [Abstract][Full Text] [Related]
13. The capsid protein of infectious bursal disease virus contains a functional alpha 4 beta 1 integrin ligand motif.
Delgui L; Oña A; Gutiérrez S; Luque D; Navarro A; Castón JR; Rodríguez JF
Virology; 2009 Apr; 386(2):360-72. PubMed ID: 19243806
[TBL] [Abstract][Full Text] [Related]
14. Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion.
Matthews QL; Sibley DA; Wu H; Li J; Stoff-Khalili MA; Waehler R; Mathis JM; Curiel DT
Mol Imaging; 2006; 5(4):510-9. PubMed ID: 17150163
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of adenoviral targeting molecules by intein-mediated protein ligation.
Nyanguile O; Dancik C; Blakemore J; Mulgrew K; Kaleko M; Stevenson SC
Gene Ther; 2003 Aug; 10(16):1362-9. PubMed ID: 12883533
[TBL] [Abstract][Full Text] [Related]
16. A system for the propagation of adenoviral vectors with genetically modified receptor specificities.
Douglas JT; Miller CR; Kim M; Dmitriev I; Mikheeva G; Krasnykh V; Curiel DT
Nat Biotechnol; 1999 May; 17(5):470-5. PubMed ID: 10331807
[TBL] [Abstract][Full Text] [Related]
17. Addition of a short peptide ligand to the adenovirus fiber protein.
Michael SI; Hong JS; Curiel DT; Engler JA
Gene Ther; 1995 Nov; 2(9):660-8. PubMed ID: 8548556
[TBL] [Abstract][Full Text] [Related]
18. A cathepsin-cleavage site between the adenovirus capsid protein IX and a tumor-targeting ligand improves targeted transduction.
de Vrij J; Dautzenberg IJ; van den Hengel SK; Magnusson MK; Uil TG; Cramer SJ; Vellinga J; Verissimo CS; Lindholm L; Koppers-Lalic D; Hoeben RC
Gene Ther; 2012 Sep; 19(9):899-906. PubMed ID: 22011643
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus targeting to HLA-A1/MAGE-A1-positive tumor cells by fusing a single-chain T-cell receptor with minor capsid protein IX.
de Vrij J; Uil TG; van den Hengel SK; Cramer SJ; Koppers-Lalic D; Verweij MC; Wiertz EJ; Vellinga J; Willemsen RA; Hoeben RC
Gene Ther; 2008 Jul; 15(13):978-89. PubMed ID: 18323790
[TBL] [Abstract][Full Text] [Related]
20. A second RGD motif in the 1D capsid protein of a SAT1 type foot-and-mouth disease virus field isolate is not essential for attachment to target cells.
Storey P; Theron J; Maree FF; O'Neill HG
Virus Res; 2007 Mar; 124(1-2):184-92. PubMed ID: 17161881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
